DRAP permits clinical trials of plasma therapy for virus treatment: Dr Zafar Mirza

ISLAMABAD: Special Assistant to the Prime Minister on National Health Services, Dr Zafar Mirza Thursday announced that Drug Regulatory Authority of Pakistan (DRAP) has allowed the local production of raw material of cholorquine as part of efforts to cope with coronavirus challenge.

In a statement, he said the DRAP has also permitted clinical trials of plasma therapy for coronavirus treatment. The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ventilators.

More than fifty companies have been allowed to produce sanitizers to contain the spread of the pandemic. The companies will prepare quality sanitizers as per the directions of the World Health Organisation.